For Practising & Retired Clinicians

Invest in the MedTech you understand better than anyone.

MedTech Syndicates gives clinicians exclusive, pre-vetted access to early-stage medical device and digital health companies — evaluated by your peers and supervised by a registered broker-dealer.

Free trial No commitment Cancel anytime

Backed by a trusted partner network

KoreIcon Capital GroupEncore Bank

Offerings conducted through a registered broker-dealer under Reg CF and Reg D 506(c).

Most recent raise

$4.2M

raised for Watershed Tx in Q1 2026

Combined across its Reg CF and Reg D 506(c) offerings

Real deals. Real clinician backing.

Watershed Tx is the most recent company to raise on MedTech Syndicates — funded by clinicians who evaluated the science, the regulatory pathway, and the market through the lens of their own practice, across both Reg CF and Reg D 506(c) offerings.

View the deal

Testing the Waters · Now open

See which companies we're exploring

Get an early look at our current cohort and share your interest.

Explore now
Clinicians as Investors

Your expertise is the edge. No one is better placed to judge a medical device than the clinicians who use them every day.

Start your free trial

Why clinicians join MedTech Syndicates

A smarter way to invest in the innovations shaping your field.

See deals before the broader market

Exclusive early access to vetted MedTech innovations before they reach wider investor networks.

Invest on your terms — from $10,000

Flexible investment sizes up to $500,000, so you can build a position that fits your own strategy.

Every deal vetted by your clinical peers

Screened by MTS and independently evaluated by practising clinicians and KOLs in the relevant specialty.

Self-directed — you choose

Unlike a fund, you select the companies you believe in. Your clinical judgement is the edge.

Built for the long game

Early-stage opportunities with a risk/return profile suited to long-term wealth building.

Go beyond investing

Optional collaboration as a KOL, Non-Executive Director, or scientific board member.

From sign-up to investment in four steps

Start free, explore real deals, and only invest when you're ready.

1

Start your free trial

Create your account in minutes and explore live, pre-vetted deals at no cost — no commitment.

2

Review KOL-vetted opportunities

Read clinical evaluations, diligence materials, and watch pitch panels hosted by clinician-investors.

3

Invest on your terms

Back the companies you believe in, from $10,000, through a compliant, broker-dealer-supervised process.

4

Track & engage

Monitor your portfolio from your dashboard and unlock optional KOL and advisory roles.

Built on rigour, not hype

Every safeguard you'd expect before putting your capital — and your name — behind a company.

Clinician-led vetting

Every opportunity is independently evaluated by KOLs in the relevant clinical specialty.

Broker-dealer supervised

SEC-compliant solicitation under Reg CF and Reg D 506(c), conducted through a registered broker-dealer.

Full transparency

Complete access to diligence materials, cap tables, and risk factors for every deal — nothing hidden.

Education-first

Webinars, deep-dive briefings, and tutorials on diligence, cap tables, and risk — so you invest informed.

More than capital

Put your clinical expertise to work through optional collaboration roles.

Key Opinion Leader (KOL)

Provide expert clinical guidance to portfolio companies.

Non-Executive Director

Serve on the board of MedTech companies you invest in.

Clinical Trials Collaboration

Design and oversee clinical studies for portfolio companies.

Product Feedback

Shape product development with hands-on clinical insights.

See the deals before you commit

Start your free trial and get full access to live, pre-vetted opportunities. Explore the platform, watch a pitch panel, and review real diligence — then decide.

Full access during your trial No upfront commitment Cancel anytime
Start your free trial

Frequently Asked Questions

Still have questions?

Start your free trial

Investing in early-stage and private companies involves a high degree of risk, including the potential loss of your entire investment. Past performance is not indicative of future results. Investments are illiquid and you should be prepared to hold them for an indefinite period.